This framing is profoundly misleading. In reality Łempicki was Polish, a civilian lawyer and public servant. There is no ...

The review of Jill Lepore’s book We the People (“Have Americans got their constitution all wrong?”, September 27) does not answer the author’s question — how long should a constitution last?

In South Africa, we’ve lived with a form of digital ID since the 1970s: one number linking births, deaths, taxes — and the ...

Contrary to what was written in your magazine feature “The agony and ecstasy of restoring Fra Angelico” (Spectrum, October 4), the Arno did not “unexpectedly burst its banks” in 1966. After a long ...

Simon Schama’s Weekend Essay “Lessons in liberty” (October 4) is right: we have forgotten the subtle but vital distinction between liberty and freedom. The Founders understood it — “Life, Liberty and ...

But design can ameliorate everyday life by improving products that will then give more pleasure in use, and perhaps be used for longer. Unfortunately it is not plausible to think that design itself ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Chancellor Rachel Reeves has urged business leaders to start talking up Britain or risk letting Nigel Farage ...

The US will allow Qatar to build an air force facility at an American military base in the western state of Idaho, as ...

When HSBC unveiled a $13.6bn deal to take full control of its local Hong Kong lender on Thursday, chief executive Georges ...

Hey you wise guys at Jonathan Cape and Penguin Press, I know I’m a slow learner but how can you be sure that the PDF that crashed screaming into your inbox earlier this year really was the latest ...

Simon Kuper’s article (Spectrum, Life & Arts, October 4) attributes moguls’ longevity to “innovations like stem-cell therapy and blood washing”. However, there is no scientific evidence for these ...

AstraZeneca has agreed to lower costs of some medicines in exchange for a three-year reprieve from US President Donald Trump’s tariffs. As part of the deal the pharmaceutical company will cut drug ...